Boiron feels impact of French homeopathy move
30 January 2020
Boiron's sales in its home market of France dropped by 12.6% in 2019, following a long debate about the pros and cons of homeopathy.
Industry News - Tag: Boiron
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
French homeopathy decision impacts Boiron
Premium
24 July 2019
Boiron's sales in its home market of France dropped by 10.5% in the first half of 2019 as the government announced plans to end reimbursement of homeopathic medicines.
Industry in brief | Boiron, Taisho/UPSA, BioGaia
2 July 2019
Boiron has criticised a French recommendation on homoeopathy, Taisho Pharmaceutical has completed its planned acquisition of UPSA, and BioGaia has announced a deal with Abbott in Uruguay.
Homoeopathy debate hurts Boiron in France
3 May 2019
Boiron said sales in its home market of France fell by 9.3% in the first quarter of 2019 as the country debated whether homoeopathy should be delisted from reimbursement.
Boiron reports significant sales drop in Europe
Premium
28 January 2019
French homoeopathy specialist Boiron reported a significant sales decline in Europe during 2018 but achieved strong growth in the rest of the world.
Companies in brief | Boiron, Ipsen, Recordati
30 October 2018
Boiron, Ipsen and Recordati have just announced financial results.
Boiron announces new general manager
Premium
10 September 2018
French homeopathy specialist Boiron will have a new general manager from 1 January 2019.
Ipsen, Boiron, Daiichi-Sankyo, Recordati in brief
1 August 2018
Ipsen Consumer Healthcare, Boiron, Daiichi-Sankyo's OTC business and Recordati have just released financial results.